Anticancer agent 347
Anticancer agent 347 is a heterobifunctional anticancer inhibitor with inhibitory activity against ERα-overexpressing cells and breast cancer cells. Anticancer agent 347 can be used for the research of breast cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3099595-91-9
- Formule: C46H53F3N10O3S
- Masse moléculaire:883.04
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
ERα |
Anticancer agent 347 (I-33) exhibits potent antiproliferative activity against MCF7 breast cancer cells (GI50 < 0.05 μM)[1].
Anticancer agent 347 exerts potent and selective antiproliferative effects on Doxorubicin (HY-15142A)-induced estrogen receptor α-overexpressing T-Rex 293 cells (GI50 < 0.05 μM), while shows extremely weak inhibitory activity against T-Rex 293 cells without high estrogen receptor α expression (GI50 > 2.5 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3099595-91-9
-
Masse moléculaire 883.04
-
Formule C46H53F3N10O3S
-
SMILES
FC(F)(F)CN1[C@H](C2=CC=C(C=N2)NC3CN(C3)CCCOCCOCCOC4=CC=C(C5=N[C@@H](C)C6=NN=C(C)N6C7=C5C(C)=C(C)S7)C=C4)C8=C(C[C@H]1C)C9=CNN=C9C=C8
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)